References to Primary Literature
- Thomas, L Discovery 1981 34–36.
- Jellinger, K Acta Neurologica Belgica 1976 76 83–102.
- Tomlinson, BE Blessed, G Roth, M Neurol. Sci. 1970 11 205–242.
- Hachinski, J Russel, RWR Symon, L Archi. Neurol. 1975 32 632–637.
- Evans, DA Funkenstein, HH Albert, MS Scherr, PA Cook, NR Crown, MJ Herbert, LE Hennekens, CH Taylor, JO Am. Med. Assoc. 1989 262 2551–2556.
- Breitner, JCS Ann. Intern. Med. 1991 115 8 601–606.
- Graves, AB Van Duijn, CM Chandra, V Fratiglioni, L Heyman, A Jorm, AF Kokmen, E Mortimer, JA Rocca, WA Shalat, SL Soininen, H Hofman, A Int. Epidemiol. 1991 20 S48–S57 (Suppl)
- Van Duijn, CM Hofman, A Br. Med J. 1991 302 1491–1494.
- Dartigues, JF Gagnon, M Michel, P Letenneur, L Commenges, D Barberger Gateau, P Auriacombe, S Rigal, B Badry, R Alperovitch, A Rev. Neurol. 1991 147 3 225–230.
- McLachlan, DRC Kruck, TP Lukiw, WJ Krishnan, SS Can. Med. Assoc. 1991 145 7 793–804.
- Martyn, CN Barker, DJ Osmond, C Harris, EC Ewardson, JA Lacey, RF Lancet 1989 1 8629 59–62.
- Cooper, JR Bloom, FE Roth, RH The Biochemical Basis of Neuropharmacology Oxford University Press 1991 328.
- Golbe, LI Farrell, TM Davis, PH Mov. Disord. 1990 5 1 0855–3185.
- Hofman, A Collette, HJ Bartelds, AI Neuroepidemiology 1989 8 6 296–299.
- Schoenberg, BS Can. Neurol. Sci. 1987 14 3 407–413.
- Stern, M Dulaney, E Gruber, SB Golbe, L Bergen, M Hurtig, H Gollomp, S Stolley, P Arch. Neurol. 1991 48 9 903–907.
- Irwin, I Langston, JW Delanney, LE Life Sci. 1987 40 8 731–740.
- Baron, JA Neurology 1986 36 11 1490–1496.
- Godwin Austen, RB Lee, PN Marmot, MG Stern, GM Neurol. Neurosurg. Psychiatry 1982 45 7 577–581.
- While numerous patents included agents for the treatment of neurological diseases, this review cites only those patents which either presented data to support potential activity or disclosed relatively unexplored potential mechanisms for neuroprotection.
- Maragos, WF Greenamyre, JT Penney, JB Young, AB Trends Neurosci. 1987 10 65–68.
- Rothstein, JD Martin, LJ Kuncl, RW New Engl. J. Med. 1992 1464–1468.
- Porsche-Wiebking, E Drug Development Research 1989 17 367–375.
- Childers, WE Curr. Opin. Ther. Patents 1992 2 146–162.
- Perry, EK Tomlinson, BE Blessed, G Bergmann, K Gibson, PH British Medical J. 1978 2 1457–1459.
- Ellison, DW Beal, MF Mazurek, MF Bird, ED Martin, JB Arch. of Neurol. 1986 20 616–621.
- Hardy, JA Cowburn, R Barton, A Reynolds, GP Dodd, P Wester, P O'Carroll, AM Lofdahl, E Winblad, B Neurosci. Let. 1987 73 192–196.
- Martin, JB Gusella, JF New Engl. J. Med. 1986 315 1267–1276.
- Hornykiewicz, O Kish, SJ Adv. in Neurol. 1986 45 19–34.
- Marchbanks, RM J. Neurochem. 1982 39 9.
- Pearson, RCA Sofroniew, MV Cuello, AC Powell, TPS Eckenstein, R Eiszi, M Wilock, GK Brain Res. 1983 289 375–379.
- Jacobs, RW Butcher, LL The biological substrates of Alzheimer's disease Scheibel, AB, Wechsler, AF Academic Press New York 1986 86–100.
- Israel, M J. Biochem. 1976 160 113–115.
- Fisher, Bartus J. Neurochem. 1985 45 1085–1095.
- Ehlert J. Pharmacol. Exp. Ther. 1987 228 23–29.
- Ebinger, G Bruyland, M Martin, JJ Herregodta, P Cras, P Michotte, Y Gomme, L Neurol. Sci. 1987 77 267–283.
- Palmer, AM Francis, PT Bowen, DM Benton, JS Neary, D Mann, DM Snowden, JS Brain Res. 1987 414 365–375.
- Sparks, DL Markesbery, WR Slevia, JT Annals Neurol. 1986 19 602–604.
- Rinne, JO Sako, E Paljarvi, L Molsa, PK Rinne, UK Neurol. Sci. 1986 73 219–230.
- Rinne, JO Sako, E Paljarvi, L Molsa, PK Rinne, UK Neurotransmission 1986 65 51–62.
- Mann, DMA Yates, PO Human Neurobiol. 1986 5 147–158.
- Winblad, B Bucht, G Fowler, CJ Wallace, W Treatment Development Strategies for Alzheimer's Disease Crook, T, Bartus, R, Ferris, S, Gershon, S Mark Powley Assoc. 35–66.
- Whitford, GM Neuropsychobiol. 1986 15 133–142.
References to Patent literature
- Merrell Dow Pharm Inc US 5106847-A.
- Merrell Dow Pharm Inc EP -483881-A.
- Merrell Dow Pharm Inc WO 9201670-A.
- Warner-Lambert Co WO 9207855-A.
- Warner-Lambert Co US 5070093-A.
- Fisons Corp WO 9206957-A.
- Fisons Corp WO 9205169-A.
- Fisons Corp WO 9203420-A.
- Merck Sharp & Dohme Ltd EP -489458-A.
- Merck Sharp & Dohme Ltd EP -481676-A.
- Merck Sharp & Dohme Ltd GB 2245564-A.
- Rhone-Poulenc Rorer SA WO 9118892-A.
- GD Searle & Co WO 9203131.
- Synthelabo EP -481853-A.
- Astra AG WO 9208724.
- American Home Products US 5118675.
- University of Utah US 5064657.
- Neurogen Corp WO 9207853-A.
- Neurogen Corp WO 9200296-A.
- Adir ET Co EP -463969-A.
- John Wyeth & Brother Ltd GB 2249548-A.
- Hoechst-Roussel Pharm Inc EP -489379-A.
- Hoechst-Roussel Pharm Inc EP -477903-A.
- Hoechst-Roussel Pharm Inc US 5106856-A.
- Hoechst-Roussel Pharm Inc EP -471296-A.
- Hoechst-Roussel Pharm Inc EP -471298-A.
- Hoechst-Roussel Pharm Inc EP -468401-A.
- Hoechst-Roussel Pharm Inc EP -484573-A.
- Hoechst-Roussel Pharm Inc WO 9200072-A.
- Hoechst-Roussel Pharm Inc US 5100891-A.
- Beecham Group Plc WO 9203435-A.
- Beecham Group Plc WO 9204323-A.
- Beecham Group Plc WO 9206959-A.
- Novo Nordisk AS WO 9203433-A.
- Novo Nordisk AS WO 9203430-A.
- Eisai Co Ltd EP -468187-A.
- American Home Products US 5093333-A.
- SS Pharm Co Ltd EP -481429-A.
- Adir ET Co EP -475844-A.
- Pfizer Inc WO 9200961-A.
- Boehringer Ingelheim GmbH WO 9200297-A.
- Sigma-Tau Ind Farm Riunite Spa EP -488965-A.
- Mediolanum Farm Spa EP -486958-A.
- Takeda Chem Ind Ltd EP -487071-A.
- Mayo Fdn US 5104880-A.
- Biorex Kutato-Fejleszto Kft WO 9200737-A.
- Nippon Shinyaku Co Ltd WO 9204333-A.
- Merck Sharp & Dohme EP -473442-A.
- Fisons Corp US 5073560-A.
- Sumitomo Pharm Co Ltd EP -476933-A.
- Warner-Lambert Co WO 9207831-A.
- Warner-Lambert Co WO 9207832-A.
- Abbott Labs WO 9204356-A.
- Novo Nordisk AS WO 9201686-A.
- Akzo NV EP -468562-A.
- Upjohn Co WO 9200282-A.
- Fujisawa Pharm Co Ltd EP -481342-A.
- Novo Nordisk AS WO 9201679-A.
- Smith Kline & French WO 9200735-A.
- DuPont Merck Pharm Co WO 9200760-A.
- Beecham Group Plc WO 9205170-A.
- ER Squibb & Sons Inc EP -481207-A.
- Dainippon Pharm Co Ltd EP -484988-A.
- Harvard College WO 9203474-A.
- Upjohn Co WO 9206187-A.
- Children's Medical Centre Corp WO 9208483.
- Wehling P WO 9119508-A.
- CNRS WO 9118981-A.
- Warner-Lambert Co US 5075305-A.
- Salter Labs SA WO 9118607-A.
- Suntory LTD EP -460358-A.
- University of California WO 9205272-A.
- University of California WO 9204442-A.
- Takeda Chem Ind Inc EP -470604-A.
- American Cyanamid Co EP -476233-A.
- New York University WO 9206702-A.
- Dana Farber Cancer Inst WO 9207945-A.
- Nova Pharm Co Ltd WO 9203415-A.
- Ono Pharm Co Ltd EP -461677-A.
- Orion-Yhtyma OY WO 9118886-A.
- Warner-Lambert Co US 5068237-A.
- Adir et Co EP -470317-A.
- Adir et Co EP -486386-A.
- Pfizer Inc WO 9118891-A.
- Daiichi Pharm Co Ltd EP -464206-A.
- Bristol-Myers Squibb Co EP -463596-A.
- Ludke HW WO 9201455-A.
- Novo Nordisk AS WO 9201672-A.
- Children's Medical Centre Corp WO 9203137-A.
- Children's Medical Centre Corp WO 9202248-A.
- SmithKline & French Labs Ltd WO 9202502-A.
- Farmitalia Carlo ERBA SRL WO 9202224-A.
- Pulitzer Italiana SRL WO 9202498-A.
- Burzynski SR WO 9204043-A.
- Mount Sinai School Medicine WO 9207936-A.
- Depha Team SRL WO 9206980-A.
- Elan Corp Plc EP -484186-A.
- Arzneimittelwerk Dresden EP -484660-A.
- Biosource Genetics Corp WO 9207580-A.
- Kyowa Hakko Kogyo Co Ltd WO 9206976-A.
- Children's Medical Centre Corp WO 9207562-A.
- Leland Stanford Junior University WO 9202137-A.